397O Avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients as a rechallenge strategy: The phase II CAVE (cetuximab-avelumab) mCRC study

Authors:
  • EME. Martinelli
    E. Martinelli
  • GMG. Martini
    G. Martini
  • TTT. Troiani
    T. Troiani
  • FPF. Pietrantonio
    F. Pietrantonio
  • AAA. Avallone
    A. Avallone
  • NNN. Normanno
    N. Normanno
  • ANA. Nappi
    A. Nappi
  • EME. Maiello
    E. Maiello
  • AFA. Falcone
    A. Falcone
  • GSG. Santabarbara
    G. Santabarbara
  • CPC. Pinto
    C. Pinto
  • DSD. Santini
    D. Santini

Abstract
No abstract available